Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Rigel Pharmaceutical Inc. | 13 | 0 | 3 | 0 | €0.74 | €13.82 | 1767.203% |
| Biogen Inc. | 53 | 1 | 5 | 0 | €216.60 | €292.88 | 35.215% |
| Amgen Inc. | 28 | 0 | 4 | 0 | €291.80 | €300.61 | 3.019% |
| Repligen Corp. | 14 | 0 | 1 | 0 | €118.30 | €182.96 | 54.658% |
| Immunogen Inc. | 4 | 0 | 0 | 0 | €28.97 | - | - |
| Natural Alternat. | 18 | 1 | 1 | 0 | €5.60 | - | - |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 11 | 0 | €982.60 | €1,046.4 | 6.489% |
| Ionis Pharmaceuticals Inc. | 20 | 5 | 1 | 0 | €44.51 | €56.72 | 27.436% |
| Vertex Pharmaceuticals Inc. | 52 | 2 | 6 | 0 | €437.65 | €432.21 | -1.244% |
| Gilead Sciences Inc | 15 | 1 | 4 | 0 | €64.05 | €79.54 | 24.189% |
| Anika Therapeutics | 5 | 0 | 0 | 0 | €24.00 | €28.29 | 17.878% |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | €5.78 | €11.05 | 90.996% |
| Incyte Corp. | 12 | 2 | 0 | 0 | €56.60 | €78.05 | 37.892% |
| Novavax Inc. | 5 | 1 | 0 | 1 | €11.82 | €17.59 | 48.884% |
| Neurocrine Bioscience | 33 | 0 | 4 | 0 | €128.55 | €140.87 | 9.582% |
| Geron Corp. | 16 | 0 | 4 | 0 | €3.96 | €5.56 | 40.541% |
| Sarepta Therapeutics | 8 | 0 | 7 | 0 | €147.55 | €190.00 | 28.770% |
| United Therapeutics | 22 | 0 | 3 | 0 | €297.30 | €289.92 | -2.482% |
| BioMarin Pharmaceutical Inc. | 21 | 0 | 1 | 0 | €79.28 | €102.63 | 29.453% |
| Dynavax Technologies Corp | 3 | 0 | 1 | 0 | €10.33 | €27.02 | 161.660% |
| Lexicon Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €1.57 | €7.66 | 386.372% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.95 | €26.01 | 24.136% |
| Innoviva Inc. | 4 | 0 | 1 | 0 | €15.20 | €30.00 | 97.368% |
| Cytokinetics Inc. | 34 | 1 | 4 | 0 | €48.40 | €83.21 | 71.911% |
| Arrowhead Pharmaceuticals Inc. | 20 | 2 | 6 | 0 | €24.24 | €54.74 | 125.842% |